Variable | Recurrence or Progression | No Recurrence or Progression | p-value |
---|---|---|---|
Total no. of patients | 90 | 115 | – |
Age, mean (SD) | 73.6 (10.8) | 70.6 (11.8) | 0.07+ |
Gender, n (%) | 0.81 | ||
Male | 74 (82.2) | 93 (80.9) | |
Female | 16 (17.8) | 22 (19.1) | |
Grade, n (%) | 0.38 | ||
High | 47 (52.2) | 53 (46.1) | |
Low | 43 (47.8) | 62 (53.9) | |
Stage, n (%) | 0.09* | ||
Ta without CIS | 55 (61.1) | 71 (61.7) | |
Ta with CIS | 3 (3.3) | 9 (7.8) | |
T1 without CIS | 14 (15.6) | 22 (19.1) | |
T1 with CIS | 5 (5.6) | 8 (7.0) | |
CIS | 13 (14.4) | 5 (4.4) | |
Tumor size, n (%) | 0.09 | ||
< 0.5 cm | 14 (15.6) | 6 (5.2) | |
0.5–2.0 cm | 37 (41.1) | 53 (46.1) | |
2.0–5.0 cm | 17 (18.9) | 28 (24.4) | |
> 5.0 cm | 22 (24.4) | 28 (24.3) | |
Multiplicity of tumor, n (%) | 56 (62.2) | 49 (42.6) | < 0.01 |
Recurrent disease, n (%) | 42 (46.7) | 33 (28.7) | < 0.01 |
AUA Risk Stratification | 0.07 | ||
Low risk | 9 (10.0) | 14 (12.2) | |
Intermediate risk | 28 (31.1) | 52 (45.2) | |
High risk | 53 (58.9) | 49 (42.6) | |
Restaging resection, n (%) | 12 (13.3) | 24 (20.9) | 0.16 |
Adjuvant therapy, n (%) | 32 (35.6) | 54 (47.0) | 0.10 |
Perioperative treatment, n (%) | 0.004 | ||
None | 47 (52.2) | 42 (36.5) | |
MMC | 20 (22.2) | 51 (44.4) | |
CSBI | 23 (25.6) | 22 (19.1) |